Pharma Business Week articles from April 2003

Pharma Business Week archives from April 2003

Study to determine the effects of statins and C-reactive protein.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- AstraZeneca has announced initiation of a long-term clinical study to examine whether the company's investigational statin Crestor (rosuvastatin calcium) can reduce the risk of major cardiovascular...

Common heart surgery drug potentially dangerous.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Protamine, a drug used for more than 40 years immediately after coronary artery bypass surgery to return thinned blood to its normal state, has been shown to have more potential negative side effects...

ASDS pushes for education on use of new wrinkle fillers.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- A spate of new face-smoothing injectables will transform the wrinkle-filler market in the United States, according to dermatologic surgeon Dr. Alastair Carruthers who recently returned from meetings...

Prime launches consumer-directed pharmacy benefit product.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- A new consumer-directed product designed exclusively for prescription drug spending will be introduced by Prime Therapeutics, Inc., a pharmacy benefit solutions company. The first of its kind in...

Survey reveals which pharmas are tops with physicians.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Six out of 12 physician specialty segments surveyed rated Pfizer as the top company who best supports the overall needs of their practices, according to recent information collected by Health Products...

America's focus on wellness creates opportunity for pharmaceutical retailers.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Retailers and prescription drug and consumer healthcare products manufacturers must evolve their traditional approaches to marketing and begin seeking new ways of understanding the total wellness needs...

Biotechnology company expands collaboration with University of Melbourne.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology, Ltd., (PRAN) announced a substantial expansion to its existing University of Melbourne agreement to lengthen the collaboration by 2 years to 2006 while intensifying research into...

Todd Davis joins board of San Diego-based pharmaceutical company.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Prometheus Laboratories, Inc., a specialty pharmaceutical company based in San Diego, California, announced the election of Todd Davis of Apax Partners, Inc., to its board of directors. Davis is a...

OmniComm selected by CINRG to provide worldwide clinical data services.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- OmniComm Systems, Inc., (OMCM), the developer of internet-based technology solutions that streamline the process of collecting, validating, and managing clinical trial data, has announced that CINRG,...

Supply agreement finalized for additional cGMP manufacturing runs.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Avid Bioservices, Inc., a wholly-owned subsidiary of Peregrine Pharmaceuticals (PPHM), announced that it has completed its initial manufacturing contract with Inhibitex, Inc., of Atlanta, Georgia,...

$15M private placement completed.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM) announced that the company closed and funded its $15 million private placement financing on March 10, 2003. Further, the company received a majority approval of the...

Peptimmune secures $41.2 million in venture capital financing.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Peptimmune, Inc., has secured $41.2 million in a first-round of venture capital financing to accelerate the development of specific targeted immunotherapeutics for the treatment of a broad range of...

Pegasys a more tolerable treatment, study reveals.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Two weeks after initiating treatment with Pegasys, a new study has found that hepatitis C patients experienced significantly less fatigue, pain, physical, and emotional limitations and had improved...

Antihypertensive therapies shelved after disappointing phase III trial results.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., finds that a number of novel therapies for the antihypertensive market are now unlikely to drive the value of the market because of disappointing phase III clinical trial...

Study to assess affect of technology on physician prescribing behaviors.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Aetna, Advanced Concepts USP, and the University of Pennsylvania Health System's primary care physician network, Clinical Care Associates, announce the commencement of the e-Prescribing Research Series....

Class action lawsuit filed for violations of securities laws.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Notice was filed that Glancy & Binkow LLP commenced a Class Action lawsuit in the United States District Court for the Eastern District of Tennessee on behalf of a class consisting of all persons who...

Class action lawsuit filed on behalf of investors.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- The Law Firm of Cauley Geller Bowman Coates & Rudman, LLP announced that a class action lawsuit has been filed in the United States District Court for the Eastern District of Tennessee, Northeastern...

Fewer new drugs hit the market in 2002.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Industry experts estimate 47 new drugs hit the market in 2002 - a third fewer than in 1997. According to a new study, with each drug carrying more weight, starving potential blockbusters is one of...

Pharmaceutical research highlights new customer retention opportunities.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies can improve lifetime customer value by positioning themselves as disease experts and providing valuable disease management information. In fact, the best path toward...

Anti-MIF technology licensed to large pharmaceutical company.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Cytokine PharmaSciences, Inc., has signed an exclusive license with Baxter Healthcare Corporation for rights to Cytokine's antimacrophage migration inhibitory factor (MIF) antibody technology. The...

Survey: Creams preferred to pills for pain.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- A recent survey conducted by SmartScience Laboratories, maker of JointFlex Pain Relieving Cream, in conjunction with PKS Research Partners, found that more people, age 40-plus, would rather rub on a...

Senetek announces Kinetin agreement for Taiwan and Hong Kong.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Senetek, PLC, (SNTK), a healthcare technologies company focused on developing and comarketing products applicable to the antiaging markets in key skin care/dermatologicals and sexual dysfunction...

Alinia now available in pharmacies.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Romark Pharmaceuticals has announced that its new U.S. Food and Drug Administration (FDA)-approved pediatric diarrhea drug, Alinia (nitazoxanide), is now available in pharmacies through national and...

Fred Banti named VP of corporate development.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Penwest Pharmaceuticals Co. (PPCO) announced that Fred Banti has joined the company as vice president of corporate development. Banti, 46, has held marketing and business development positions at...

Drug cost calculator to help Blue Cross and Blue Shield of Nebraska members.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Blue Cross and Blue Shield of Nebraska and Prime Therapeutics, a pharmacy benefits solutions company, have created My RxHealth to educate Nebraskans about the retail cost of a wide range of prescription...

PDI, Inc., adopts MedManage's eMedSample.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- MedManage Systems, a provider of prescription drug sampling solutions, announced that PDI, Inc., a commercial sales and marketing provider to the biopharmaceutical and medical devices and diagnostics...

ACS helps states achieve savings in Medicaid benefits programs.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- ACS announced that its pharmacy benefits management (PBM) programs continue to be very successful in helping clients generate cost savings. ACS has assisted six state Medicaid and other healthcare...

Xcelodose licensed to top pharmaceutical companies.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Meridica, Ltd., announced that it has licensed its new precision automated powder filling system, Xcelodose, to 5 out of the top 10 global pharmaceutical companies for use in the early stage clinical...

Many patients still missing out on drugs to cut heart attacks and stroke.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- Many patients who need statins to cut their risk of heart attacks and stroke are missing out, particularly the elderly, finds new research. The authors tracked statin prescribing habits from 1994 to...

$36B women's health prescription drug market to double by 2007.
April 7, 2003... 2003 APR 7 - (NewsRx.com & NewsRx.net) -- The worldwide market for prescription drugs for women's health will nearly double by the year 2007, according to a new study released by Kalorama Information. Manufacturers' revenues for 2002...

SPE-LC-MS/MS assay for Eplerenone and metabolite in human urine validated.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- A solid phase extraction, liquid chromatography-tandem mass spectrometry assay for Pharmacia's selective aldosterone blocker, Eplerenone, and its hydrolyzed metabolite in human urine was validated in a...

Valdecoxib plus morphine reduces pain, opioid use.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Pharmacia Corp.'s COX-2 specific inhibitor, valdecoxib, when combined with morphine, reduces post-operative pain and opioid drug use in patients recovering from knee replacement surgery. Company...

UAB develops assay that could lead to HIV vaccine.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Tranzyme, Inc., a drug discovery and development company, announced that researchers at the University of Alabama at Birmingham (UAB) have developed a novel assay that may lead to an AIDS vaccine...

Pharmagenesis enters agreement for anticancer drug based on Chinese herbs.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Pharmagenesis, Inc., has signed an agreement with Pierre Fabre Medicament (PFM), a European company that has pioneered the use of natural extracts for pharmaceutical and dermatological products, to...

Helitest adapted for pharmaceutical applications.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Varian, Inc., (VARI) announced that its Helitest portable leak detector has been adapted to address the challenging requirements of pharmaceutical companies testing biovessels and bioreactors for...

Pharmaceutical industry gearing up for flood of generics.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- With the recent surge of activity surrounding generic drugs, the U.S. pharmaceutical industry is bracing itself for a period of intense competition. Marketers of branded drugs and generic drug...

Patent issued for formulation and use of vitamin D for cancer treatment.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Oregon Health & Science University (OHSU) and Novacea, Inc., announced that OHSU has been issued U.S. Patent No. 6,521,608 for "Vitamin D and its analogs in the treatment of tumors and other...

Agreement reached for the production of cancer vaccine.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX; GX1) announced a contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP genes...

Genomics company to supply GeneChip Tag Arrays.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) and ParAllele Bioscience announced an agreement under which Affymetrix will supply Par Allele with GeneChip Tag Arrays for use in combination with ParAllele's proprietary "lab...

NBTY ceases ephedra sales.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- NBTY, Inc., (NBTY) announced that the company discontinued sales of products that contain ephedra. As a result, NBTY will take a one-time charge of approximately $6 million. Scott Rudolph,...

MicroIslet, TSRI collaborate on treatment of insulin dependent diabetes.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- MicroIslet, Inc., (MIIS) and The Scripps Research Institute (TSRI) announced that they have entered a broad collaboration in the area of islet cell transplantation therapies for treatment of...

Losses to be recovered for investors who purchased IT company securities.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- The Law Firm of Cauley Geller Bowman Coates & Rudman, LLP announced that a class action lawsuit has been filed in the United States District Court for the District of Connecticut on behalf of...

Second favorable decision announced in Sands Brothers proceeding.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corporation (GNBT) announced that on March 18, 2003, the Appellate Division (First Department) of the New York Supreme Court denied a motion by Sands for re-argument of the...

Study on healthcare trends in America released.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- As Congress and President Bush wrestle with a return to deficit spending, and as millions of Americans prepare to pay their federal income taxes, a timely new independent study shows that much of the...

Big pharmas should prepare for the next generation of blockbusters.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies that fail to invest in critical launch activities risk hundreds of millions in lost revenue, according to a new report by pharmaceutical intelligence firm Cutting Edge...

Patient enrollment completed in investigational phase III study of decitabine.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc., (SUPG) announced that patient enrollment has been completed in an open-label, randomized phase III clinical study of decitabine, an investigational treatment for advanced...

Bupropion triples quit rates among women, formerly depressed smokers.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- The use of the antidepressant sustained release bupropion triples quit rates among women and smokers with a history of depression as compared to placebo, according to a new study just published in...

U.S. patent granted for therapeutic angiogenesis in humans.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC) announced the issuance of U.S. patent no. 6,158,255 covering the use of adenovector products administered by multiple injections, in tissue including the heart, to effect...

FDA proposes bar coding in pharmaceutical packaging.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Datamax Corporation is encouraged by the recent U.S. Food and Drug Administration (FDA) proposal that mandates the use of bar coding at the unit of use pharmaceutical packaging level. The FDA...

Steven King named president and CEO.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals, Inc., (PPHM) announced that COO Steven King has been named president and chief executive officer. In addition to serving as chief operating officer, King has been...

Many P-gp substrates don't inhibit transport process across cell membranes.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Many P-glycoprotein substrates don't inhibit the transport process across cell membranes, say researchers with Schering Plough Corp. "The critical role of P-glycoprotein (P-gp) in the clinical...

360 Service centers to give seniors access to Canadian drugs.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Undeterred by the U.S. Food and Drug Administration's recent scrutiny over American seniors buying low-priced Canadian drugs, the American Drug Club pharmacy service announced that by year's end, it...

Care management company introduces new pharmacy benefit management program.
April 14, 2003... 2003 APR 14 - (NewsRx.com & NewsRx.net) -- Care Network, Inc., (CNI) has introduced an innovative pharmacy benefits program (PBM) designed to actively monitor the use of prescription drugs while containing rapidly escalating pharmaceutical...

Safe vaccine developed.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- The unpleasant and painful sores, and infection of newborn babies caused by the genital herpes virus could soon be a thing of the past according to Dr. Julian Hickling, who presented results from...

Vaccine helps reduce transmission of disease.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Vaccination for pertussis is highly effective in reducing transmission of the disease from person to person, even in "breakthrough" cases in which a vaccinated individual still develops pertussis,...

DHEA supplement shows no effect.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- The supplement dehydroepiandrosterone, or DHEA, which has been touted by some as an antiaging hormone and a treatment for diseases such as cancer, AIDS, diabetes, and Alzheimer disease, showed no...

Study: Donepezil HCl effective in treating patients with severe AD.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Severe Alzheimer disease (AD) patients treated with Aricept (donepezil HCl tablets) showed significant improvement in global function, cognition, behavior, and activities of daily living versus...

Rosiglitazone may also lower cardiovascular disease risk.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- New data presented at the 52nd annual scientific session of the American College of Cardiology showed that the type 2 diabetes treatment rosiglitazone increased "good" cholesterol levels and improved...

SIRIUS trial confirms cost-effectiveness of Sirolimus-eluting coronary stent.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Substantial reductions in the need for retreatment and rehospitalization will enable payers to recoup virtually all costs associated with the CYPHER Sirolimus-eluting coronary stent by 1 year...

Tampa company acquires TEAMM Pharmaceuticals.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Accentia, Inc., based in Tampa, Florida, has acquired TEAMM Pharmaceuticals, Inc., as a wholly owned subsidiary. Terms of the deal were not disclosed. Accentia is a comprehensive specialty...

Japanese company enters license agreement for new anti-infective.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc., announced it has entered into a license agreement with Daiichi Pharmaceutical Co., Ltd., of Japan for a potential new anti-infective agent that has been shown in preclinical testing to be...

Software deployed for web content, digital asset management.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Documentum (DCTM) announced that AstraZeneca (AZN) has expanded its use of the Documentum ECM platform to include web content management and digital asset management. The Documentum products are...

$25M convertible term loan taken, merger announced.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- AEterna Laboratories, Inc., (AEL, AELA) announced that, on March 31, 2003, it entered into a term loan facility with two strategic investors: SGF Sante, Inc., and Solidarity Fund QFL. The term...

Biotech company files for issuance of warrants at $0.10.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIOHF.OB: OB; BIO.V) announced that the company has filed with the TSX Venture Exchange for issuance of 10 million warrants, at $0.10 per share. The...

Total artificial heart implantation assessed.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- The total artificial heart (TAH) could benefit several thousand people each year in the United States if it is eventually proven to be safe and effective, according to a new ECRI evidence report. ...

Clinical testing of Hepavir B begins.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Metabasis Therapeutics, Inc., (Metabasis) announced that Ribapharm, Inc., (Ribapharm) has begun clinical testing of Hepavir B, an orally active, liver-specific prodrug of the proven antiviral agent...

Additional Symlin information submitted to Swiss regulatory authorities.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) announced that it has submitted a response to inquiries from the Swiss Regulatory Authorities (Swissmedic) in connection with its review of the marketing...

Trends: IT spending to shift to integration of enterprise-wide processes.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies will increasingly shift their IT spending from systems that support a single function or department to systems that will help them integrate business processes and share data...

Trial to study safe methodologies to help diabetics achieve glycemic control.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Insulin therapy can effectively help patients with diabetes achieve tight blood sugar control, defined by the American Diabetes Association (ADA) as an A1C A clinical trial announced, called GOT...

Class action suit filed against pharmaceutical company.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- The law firm of Berger & Montague, P.C. announced that a class action lawsuit was filed on March 27, 2003, on behalf of purchasers of the securities of King Pharmaceuticals, Inc., between April 26,...

Biotech investors still sitting on the sidelines.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- With the capital markets continuing their downward trend in the first quarter of 2003 (DJIA down 4% YTD, NASDAQ even YTD), the capital markets continued to be challenging for the biotech industry. ...

Consumer awareness spurs demand for convenient glucose self-monitoring devices.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- An increasingly savvy consumer base coupled with the growing incidence of diabetes are spurring the growth of the glucose self-monitoring devices markets. With healthcare specialists and...

Consumerism theme resonates at healthcare symposium on Capitol Hill.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- In a day-long symposium on Capitol Hill, consumerism was the overriding solution to the top healthcare affordability challenges in America. Among the issues addressed at "Toward Affordable Health...

NDCHealth enters agreement to provide Dutch pharmaceutical market data.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- NDCHealth Corp. (NDC) announced an agreement with Farminform, an independent provider of pharmaceutical market data in The Netherlands. Under the terms of the agreement, NDCHealth will provide its...

Drug development company promotes key managers.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- PRA International, Inc., a global drug development organization, announced several promotions that will support the company plans for continued global expansion. Headquartered in McLean, Virginia,...

Alliance to identify novel uses for existing cancer drugs.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- cABC2, CaP CURE, and Ingenuity Systems announced a partnership that will test existing chemotherapeutic agents against recently discovered gene defects associated with prostate and brain cancer...

Teichman named chief development officer.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- ARYx Therapeutics, Inc., announced the appointment of Sam L. Teichman, MD, to the position of vice president and chief development officer. In this position, Teichman will be responsible for the...

15-Day extension for form 10-K filed by pharmaceutical company.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) filed a Form 12b-25 providing for a 15-calendar-day extension for submitting its Form 10-K for the year ended December 31, 2002, to the U.S. Securities and Exchange...

OTCs offer mixed bag.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- For some marketers of over-the-counter medications, 2002 represented yet another year of flat or slipping sales, while for others, it yielded impressive growth. One of the key factors for this...

Pain management market estimated to reach $29.8B by 2008.
April 28, 2003... 2003 APR 28 - (NewsRx.com & NewsRx.net) -- Front Line Strategic Consulting, Inc., announced the completion of its new Strategic Market Report series, "Pain Management Therapeutics." Front Line's report includes an in-depth analysis of...